EXHIBIT 32.2

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Financial Officer of Genome Therapeutics Corp. (the “Company”) does hereby certify that to my knowledge:

1) the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2002 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) the information contained in the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2002 fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ STEPHEN COHEN

Stephen Cohen

Senior Vice President and Chief Financial Officer

Dated: September 29, 2003